Literature DB >> 21302063

The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.

P R Avner1, W F Dove, P Dubois, J A Gaillard, J L Guénet, F Jacob, H Jakob, A Shedlovsky.   

Abstract

Two cultured lines of murine embryonal carcinoma, F9 and PCC3, have been grafted to a variety of allogeneic hosts. The host strains have been classified by their resistance or sensitivity to these carcinomas. Resistance seems to be immunological in nature.Allograft rejection does not correlate withH-2 haplotype, and seems to be controlled by a limited number of recessive factors, presumably histocompatibility genes. We infer that these factors have limited polymorphism in the mouse species. Recombinational analysis of strain A/He has revealed the presence of a recessive factor linked to theH-2 locus. Tumor resistance of strains C57BL/6 and AKR appears to result from the interaction of dominant or semi-dominant factors in theH-2 region with other recessive elements in the genetic background.Though F(1) hybrids between resistant mouse strains and the syngeneic strain 129 are largely tumor-sensitive, a low level of hybrid resistance to F9 has been observed and shown to be eliminated by X-irradiation.

Entities:  

Year:  1978        PMID: 21302063     DOI: 10.1007/BF01843995

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  24 in total

Review 1.  Teratocarcinomas as a model system for the study of embryogenesis and neoplasia.

Authors:  G R Martin
Journal:  Cell       Date:  1975-07       Impact factor: 41.582

2.  Experimental production of testicular teratomas in mice of strains 129, A/He, and their F1 hybrids.

Authors:  L C Stevens
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

Review 3.  TRANSPLANTATION IMMUNITY AND THE MATERNAL-FETAL RELATION.

Authors:  R E BILLINGHAM
Journal:  N Engl J Med       Date:  1964-03-26       Impact factor: 91.245

4.  [Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells].

Authors:  H Jakob; T Boon; J Gaillard; J Nicolas; F Jacob
Journal:  Ann Microbiol (Paris)       Date:  1973-10

5.  [Mouse teratocarcinoma: cytogenetic studies of multipotential cells (author's transl)].

Authors:  J L Guénet; H Jakob; J F Nicolas; F Jacob
Journal:  Ann Microbiol (Paris)       Date:  1974 Feb-Mar

6.  Histocompatibility genes of mice. XI. Evidence establishing a new histocompatibility locus, H-12, and new H-2 allele, H-2bc.

Authors:  G D Snell; R J Graff; M Cherry
Journal:  Transplantation       Date:  1971-06       Impact factor: 4.939

7.  The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos.

Authors:  L C Stevens
Journal:  Dev Biol       Date:  1970-03       Impact factor: 3.582

8.  Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes.

Authors:  D W Bailey
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

9.  Alkaline phosphatase activity in mouse teratoma.

Authors:  E G Berstine; M L Hooper; S Grandchamp; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture.

Authors:  K Artzt; P Dubois; D Bennett; H Condamine; C Babinet; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

View more
  14 in total

1.  Susceptibility of allogeneic mice to teratocarcinoma 402AX.

Authors:  S Ostrand-Rosenberg; T M Rider; A Twarowski
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  Transfected H-2Kb gene as a cause of embryonal carcinoma cell rejection in vivo.

Authors:  B Mosinger; J Forejt
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.

Authors:  L J Maher; W F Dove
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Growth conditions of F9 embryonal carcinoma cells affect the degree of DNA methylation.

Authors:  R P Erickson; S Ferrucci; B Rahe; M P Rosenberg; D Morello
Journal:  Mol Biol Rep       Date:  1984-12       Impact factor: 2.316

5.  Male-specific transplantation antigen expression by XY teratocarcinomas PCC7 and 7'.

Authors:  L L Johnson; W F Dove
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

Review 6.  H-2 haplotypes, genes, and antigens: second listing. I. Non-H-2 loci on chromosome 17.

Authors:  J Klein; F Figueroa; D Klein
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses.

Authors:  M C Simmler; P Avner; J P Levy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

8.  Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.

Authors:  A Shedlovsky; L J Clipson; J L VandeBerg; W F Dove
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

9.  Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.

Authors:  S Ostrand-Rosenberg; V Clements
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles.

Authors:  A J Levine; A K Teresky
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.